# OnCo record rejuv-agenda-no-agreed-outcome-measures (bottleneck). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/bottlenecks/rejuv-agenda-no-agreed-outcome-measures/>
  a schema:Thing ;
  onco:kind "bottleneck" ;
  schema:identifier "rejuv-agenda-no-agreed-outcome-measures" ;
  schema:name "The field cannot pool its own studies, because it has not agreed what to measure"@en ;
  schema:description "On subject after subject here, the studies exist and cannot be combined, because each used a different definition, a different questionnaire or a different threshold. A prevalence that ranges from 0 to 84 per cent is a measurement problem, not a biological one."@en ;
  schema:url <https://onco.cc/bottlenecks/rejuv-agenda-no-agreed-outcome-measures/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2013.6296> ;
  onco:tag "rejuvenation", "survivorship", "open-problem", "outcomes", "methods" ;
  onco:related <https://onco.cc/technologies/rejuv-paed-kidneys/>, <https://onco.cc/technologies/rejuv-ayac-diagnostic-delay/>, <https://onco.cc/technologies/rejuv-mind-body-after-stoma-and-limb-loss/>, <https://onco.cc/technologies/rejuv-mind-fear-of-recurrence/>, <https://onco.cc/technologies/rejuv-mind-visible-difference-head-and-neck/>, <https://onco.cc/technologies/nail-changes-after-chemotherapy/>, <https://onco.cc/technologies/bowel-after-pelvic-radiotherapy/>, <https://onco.cc/technologies/cognitive-impairment-after-cancer-treatment/>, <https://onco.cc/ideas/idea-rejuv-core-outcome-set-for-late-effects/>, <https://onco.cc/ideas/idea-moon-pro-ctcae-in-every-pivotal-trial/>, <https://onco.cc/collections/ighg/>, <https://onco.cc/roadmaps/rejuvenation-roadmap/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> .